Search

everythinglearnresearchcommunity

for

Search:↓

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Some chemotherapy can cause permanent hair loss.

Blocking certain proteins in mouse skin can reduce and shrink skin tumors.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Nilotinib can cause keratosis pilaris, a skin condition.

A new compound from a sponge strongly inhibits an enzyme linked to male-pattern hair loss without being toxic at low levels.

Minoxidil and a solvent mixture can prevent hair loss caused by chemotherapy in mice.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Ruxolitinib cream may help treat severe hair loss in children.